The Application segment dissects the 14-26F Abdominal Aortic Stent Graft market according to procedural intent, a primary driver of device selection and volume. Elective repair accounts for the majority of cases, reflecting scheduled interventions where pre‑operative imaging permits optimal graft sizing and deployment; it contributes roughly 60 % of total market revenue. Emergency repair, encompassing ruptured aneurysm and symptomatic presentations, demands rapid device availability and therefore represents about 30 % of the market, with a premium on inventory readiness and streamlined logistics. A smaller but growing niche, Hybrid procedures, combines endovascular grafting with open surgical adjuncts for complex anatomies, and currently captures near 10 % of the market. These application categories directly influence manufacturing throughput, pricing strategies, and regional adoption patterns, making the 14-26F Abdominal Aortic Stent Graft segmentation essential for forecasting demand across hospital tiers and reimbursement environments. Furthermore, the reimbursement landscape varies by application, with elective cases often covered under bundled payments, whereas emergency procedures may trigger higher DRG reimbursements, amplifying the financial impact of each segment on overall market size.
